SCHEMBL19762896

SCHEMBL19762896

Cc1cc(O)c2cccc(N)c2c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.52
▸ HSD17B10 Q99714 4/20 0.52
▸ CYP3A4 P08684 3/20 0.52
▸ TSHR P16473 3/20 0.52
▸ HPGD P15428 2/20 0.52
▸ TDP1 Q9NUW8 1/20 0.52
▸ EP300 Q09472 2/20 0.52
▸ IDO1 P14902 2/20 0.52
▸ HDAC3 O15379 1/20 0.52
▸ KAT2B Q92831 1/20 0.52
▸ KAT8 Q9H7Z6 1/20 0.52
▸ NCOR2 Q9Y618 1/20 0.52
▸ PKM P14618 1/20 0.46
▸ PARP1 P09874 2/20 0.44
▸ LMNA P02545 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ PTPN1 P18031 1/20 0.43
▸ NR4A2 P43354 1/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ ESR1 P03372 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4659312 0.83 ALDH1A1 (0.62) ALDH1A1HSD17B10CYP3A4TSHRHPGD
SCHEMBL9232253 0.81 LMNA (0.48) ALDH1A1HSD17B10CYP3A4TSHRHPGD
SCHEMBL10551961 0.79 ALDH1A1 (0.50) ALDH1A1HSD17B10CYP3A4TSHRHPGD
SCHEMBL28942909 0.79 HTT (0.52) ALDH1A1HSD17B10IDO1PKMLMNA
SCHEMBL30277950 0.79 HTT (0.52) ALDH1A1HSD17B10IDO1PKMLMNA
SCHEMBL485855 0.78 IDO1 (0.73) ALDH1A1HSD17B10CYP3A4TSHRHPGD
SCHEMBL8006509 0.78 IDO1 (0.73) ALDH1A1HSD17B10CYP3A4TSHRHPGD
SCHEMBL8371459 0.78 IDO1 (0.73) ALDH1A1HSD17B10CYP3A4TSHRHPGD
SCHEMBL29393764 0.78 IDO1 (0.73) ALDH1A1HSD17B10CYP3A4TSHRHPGD
SCHEMBL29702452 0.78 IDO1 (0.73) ALDH1A1HSD17B10CYP3A4TSHRHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180000778-A1 SMALL MOLECULE ANTAGONISTS OF DUSP5 AND METHODS OF USE NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2018-01-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180000778-A1 SMALL MOLECULE ANTAGONISTS OF DUSP5 AND METHODS OF USE DUSP5, DUSP15, DUSP2 ALDH1A1 3103/4885HSD17B10 2434/4885CYP3A4 4874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback